1 The aim of this study was to investigate the effect of nicotinamide-adenine dinucleotide (NADH) supplementation on the metabolic condition of isolated guinea-pig ventricular cardiomyocytes. The pinacidil-primed ATP-dependent potassium current I K(ATP) was used as an indicator of subsarcolemmal ATP concentration and intracellular adenine nucleotide contents were measured. 2 Membrane currents were studied using the patch-clamp technique in the whole-cell recording mode at 36 -371C. Adenine nucleotides were determined by HPLC. 
Introduction
The reduced nicotinamide-adenine dinucleotide (NADH) plays a central role for the energetic state of a cell. NADH carries electrons derived from catabolic reactions to their entry into the respiratory chain leading to the synthesis of ATP. This electron transfer results in the formation of NAD + . The sum of NADH and NAD + is thought to be rather constant in a cell; thus the NADH/NAD + ratio is a crucial factor for its energetic state. Therefore, it is conceivable that oral application of NADH might positively affect the cellular energetic condition of humans.
Moreover, NADH serves as a cofactor for various enzyme reactions, further emphasizing the crucial role of NADH for numerous cell functions. Recent clinical studies have already demonstrated a positive effect of NADH treatment on patients suffering from Morbus Parkinson, chronic fatigue syndrome and depression (Birkmayer & Birkmayer, 1991; Birkmayer et al., 1993; Kuhn et al., 1996; Forsyth et al., 1999) . In addition, changes in NADH levels seem to correspond with stimulation and inhibition of neuronal metabolism, respectively (Rex et al., 1999) . NADH has also been identified as sensor of blood flow requirement in brain, muscle and other tissues (Ido et al., 2001) .
To test whether extracellular application of NADH affects the energetic state of a cell, we studied NADH-incubated cardiac ventricular myocytes by electrophysiological techniques.
The electrophysiological properties of a cardiomyocyte are strongly affected by its energetic condition. Especially, the ATP-dependent potassium current (I K(ATP) ) is known to link bioenergetic metabolism with membrane excitability by sensing intracellular concentrations of ATP and ADP. Under physiological conditions, K (ATP) channels are predominantly closed because of inhibition by intracellular ATP (ATP i ) (Noma, 1983; Heidbu¨chel et al., 1990; Schaffer et al., 1999) . However, when the ATP i concentration falls below certain values (like in pathological states such as acute myocardial ischemia), the K (ATP) channels open. Certain drugs known as potassium channel openers (PCOs) are able to shift the ATP sensitivity of K (ATP) channels resulting in channel opening even at physiological levels of ATP i (Arena & Kass, 1989; Nakayama et al., 1990; Tseng & Hoffman, 1990; Pelzmann et al., 2001) . Thus, the amount of I K(ATP) activation induced by these drugs serves as an indicator of the cellular ATP content (Sasaki et al., 2001) .
Studying the PCO-primed I K(ATP) , we report that supplementation of cardiomyocytes with NADH but not with the related compounds nicotinamide and NAD + results in a decrease of I K(ATP) activation by pinacidil. The NADHinduced decrease of I K(ATP) activation fits to the increase of intracellular ATP content measured by HPLC.
Methods

Myocyte isolation
Guinea-pig ventricular myocytes were isolated by Langendorff perfusion using collagenase as described previously (Piper et al., 1982) . The isolated myocytes were stored in Medium 199 (M2154, Sigma, St Louis, MO, U.S.A.), supplemented with 5 mg ml À1 penicillin, 5 IU ml À1 streptomycin, 0.5% glutamine and 5% fetal calf serum and were kept in an incubator at 371C. Experiments were performed within 24 h after isolation.
Incubation procedure
The isolated myocytes were incubated with NADH (bnicotinamide adenine dinucleotide, reduced form, disodium salt) and the related compounds nicotinamide and NAD + (bnicotinamide adenine dinucleotide, oxidized form) in equimolar amounts 4 -6 h before electrophysiological parameters and ATP content were evaluated.
Electrophysiological recordings and data analysis
Membrane currents were recorded using the whole-cell singleelectrode voltage-clamp configuration of the patch-clamp technique (Hamill et al., 1981) using a List L/M-EPC 7 amplifier (List, Darmstadt, Germany) as previously described (Pelzmann et al., 2001) . Myocytes were placed in an experimental chamber mounted on the stage of an inverted microscope (Axiovert, Zeiss, Oberkochen, Germany) and were superfused with standard extracellular solution (composition in mM: NaCl 137, KCl 5.4, CaCl 2 1.8, MgCl 2 1.1, NaHCO 3 2.2, NaH 2 PO 4 0.4, HEPES/Na + 10, D(+)-glucose 5.6, adjusted to a pH of 7.4 with NaOH) at 36 -371C with a flow rate of about 1.5 ml min
À1
. When filled with standard internal solution (composition in mM: KCl 110, ATP/K + 4.3, MgCl 2 2, CaCl 2 1, EGTA 11, HEPES/K + 10, adjusted to a pH of 7.4 with KOH) and placed into standard external solution, patchpipette tip resistances were 1 -3 MO. Only quiescent rodshaped cells with clear cross striation were used for voltageclamp experiments. Cell membrane capacitance (C m ) was determined by integration of the capacitive transient elicited by a 10 mV hyperpolarizing pulse from À50 mV. C m (up to 100 pF) and series resistance (R s , by at least 50%) were compensated. Voltage-clamp pulses were generated with a personal computer connected to a D/A and A/D converter (Digidata 1200, Axon Instruments, Foster City, U.S.A.). Data acquisition and analyses were performed using pCLAMP 5.7.1 software (Axon Instruments). In order to allow equilibration of the pipette solution with the cytosol, current recordings were started 5 min after rupture of the membrane patch.
Two experimental protocols were used. Modulation of I K(ATP) by drugs was evaluated as the change of outward current density (current amplitudes divided by C m (pA pF
) in order to compensate for variations in cell size) at +30 mV in response to a 2 s ramp from À100 to +60 mV (I ramp ). Time course of I K(ATP) activation and blockade was studied by recording the holding current at À40 mV (I hold(À40 mV) ).
Determination of adenine nucleotides
The analytical method to determine adenine nucleotides has been reported previously (Hallstro¨m et al., 2002) . Alterations of this method are in brief: separation was performed on a Hypersil ODS column (5 mm, 250 mm Â 4 mm ID) using a Waterst 717 plus Autosampler (Waters, Milford, MA, U.S.A.), two constaMetric III pumps, a gradient controller (LDC/Milton Roy, Riviera Beach, FL, U.S.A.) and a Waters 969 photodiode array detector. Detector signals (absorbance at 254 nm) were recorded with an AGC Personal Computer. The program Millennium (Waters) was used for data acquisition and analysis. Cardiomyocytes were deproteinized with 250 ml of 0.4 M perchloric acid. After centrifugation (12,000 Â g), 100 ml of the acid extract were neutralized with 10 ml of 2M potassium carbonate (41C). The supernatant (10 ml) obtained after centrifugation was used for HPLC analysis. The pellets of the acid extract were dissolved in 1 ml of 0.1 M sodium hydroxide and further diluted 1 : 10 with physiologic saline for protein determination (BCA Protein Assay, PIERCE, Rockford, IL, U.S.A.). Percentage of living cells was estimated by determining the ratio of rod-shaped to total myocytes. The percentage of rod-shaped myocytes varied between 28 and 32% in different cell preparations. At least 600 myocytes were counted in each preparation.
Statistics
Data are expressed as means7s.e.m., n ¼ number of cells. Error bars in figures represent s.e.m. Statistical significance was determined by a two-tailed Student's t-test or, if more than two conditions were compared, by one-way analysis of variance (ANOVA) with the LSD post hoc test. Differences were considered significant at Po0.05.
Drugs
Stock solutions of K (ATP) channel blocker glibenclamide and of K (ATP) channel opener pinacidil were prepared daily in DMSO. Both drugs were purchased from Sigma.
NADH (b-nicotinamide adenine dinucleotide, reduced form, disodium salt) was purchased from Roche (Mannheim, Germany), nicotinamide and NAD + (b-nicotinamide adenine dinucleotide, oxidized form) from Sigma. Figure 1 shows the effect of pinacidil on I hold(À40 mV) and I ramp . Exposure to 30 mM pinacidil caused I K(ATP) activation, shown as a strong increase in I hold(À40 mV) . Superfusion of the cell with the sulfonylurea glibenclamide (1 mM) completely inhibited I K(ATP) almost immediately, and the holding current returned to control level ( Figure 1a ). Figure 1b shows the original current traces elicited by a voltage ramp applied at different stages of the experimental protocol (indicated by letters in (a)). The current -voltage relation recorded under control conditions revealed the shape typical for ventricular myocytes. During application of pinacidil, a large increase in membrane current was observed. Addition of 1 mM glibenclamide completely reversed this effect. The glibenclamidesensitive current (inset of Figure 1b (n ¼ 19) versus 3.0270.51 pA pF À1 (n ¼ 8) using 4.3 and 1 mM ATP i , respectively). However, using 1 mM ATP i , the pinacidilinduced increase in outward current density was significantly higher compared to 4.3 mM ATP i (Po0.05). The current density was 28.373.26 (n ¼ 19) and 52.2713.8 pA pF À1 (n ¼ 8) at 4.3 and 1 mM ATP i , respectively. Thus, the pinacidil-primed I K(ATP) is an indirect indicator of subsarcolemmal ATP concentration. Figure 3 shows the concentration-dependent effect of NADH on I K(ATP) activation by 30 mM pinacidil under physiological conditions (4.3 mM ATP i ). Guinea-pig ventricular myocytes were incubated with different concentrations of NADH (200, 300, 400, 800, 1600 mg ml À1 cell culture medium) for 4 -6 h before electrophysiological experiments were performed. For À1 (n ¼ 6) at +30 mV). However, using 300 mg ml À1 , NADH outward current density was significantly reduced (13.873.78 pA pF À1 , n ¼ 6; Po0.05). A further increase of NADH concentrations did not further diminish the effect of pinacidil on I K(ATP) activation. The outward current density was 13.971.49 (n ¼ 12), 15.073.19 (n ¼ 6) and 13.273.74 pA pF À1 (n ¼ 6) in myocytes incubated with 400, 800 and 1600 mg ml À1 NADH, respectively. The effect of the K (ATP) channel opener pinacidil could be washed out completely. The outward current density returned almost to the initial value and was 1.8170.21 (n ¼ 12), 1.2470.24 (n ¼ 5), 1.0970.14 (n ¼ 5), 1.3770.25 (n ¼ 8), 1.7570.48 (n ¼ 6) and 1.2970.31 pA pF À1 (n ¼ 3) in control and after incubation with 200, 300, 400, 800 and 1600 mg ml À1 NADH, respectively. To investigate whether this decreased activation of I K(ATP) by pinacidil is a specific effect of NADH or can also be caused by related compounds, the results with 400 mg ml À1 NADH were compared with equimolar amounts of nicotinamide and NAD + (Figure 4) . Under control conditions, no difference in outward current density was observed (2.1970.26 (n ¼ 19) + and NADH, respectively). Since I K(ATP) serves as an indicator of subsarcolemmal ATP concentration, the most likely explanation for the observed effects is an NADH-induced increase in intracellular ATP content. A direct effect of extracellular NADH on pinacidilactivated I K(ATP) can be excluded. Simultaneous superfusion of myocytes with 400 mg ml À1 NADH and 30 mM pinacidil did not change I ramp (data not shown).
Effects of incubation with NADH and related compounds
Determination of intracellular adenine nucleotides
To confirm an NADH supplementation-induced increase in ATP i concentration, we measured the intracellular adenine nucleotide content in cardiomyocytes with and without NADH supplementation by HPLC. Figure 5 shows the summarized results. The increase in ATP content in cardiomyocytes after 4 h supplementation with NADH was highly significant (45.5971.88 nmol mg À1 protein of living cells versus control, 35.3572.57 nmol mg À1 protein of living cells, Po0.000005, n ¼ 7), whereas ADP and AMP showed no significant alteration compared to control.
Discussion
Almost all of the cardiac ATP is regenerated by respiratory chain-linked phosphorylation, whereby the reduction potential for the respiratory chain is mainly supplied as the reduced coenzyme NADH which is oxidized by complex I of the respiratory chain. The cellular NADH content can be influenced by extracellular supply of metabolic substrates. Recently, Williams et al. (2001) showed that because of the presence of glutamate during the isolation procedure, the intracellular glutamate concentration in single isolated rat myocytes is raised; this in turn increased metabolic flux as indicated by a higher NADH/NAD + ratio and ATP content as well as improved recovery from simulated hypoxia. The NADH/NAD + ratio can also be increased by the addition of other metabolic substrates like pyruvate (White & Wittenberg, Figure 3 Concentration-dependent effects of NADH incubation on I K(ATP) activation by 30 mM pinacidil. Numbers given represent n. *Po0.05 compared to control myocytes. ). The activity of cardiac K ATP channels is controlled by a cytosolic ATP pool for which oxidative phosphorylation is the predominat ATP source (Knopp et al., 2001) . Since the respiratory chain is fuelled mainly with NADH, it was the aim of this study to investigate, whether NADH supplementation per se leads to an improved metabolic state of cardiomyocytes. The pinacidil-primed I K(ATP) was used as sensor of the subsarcolemmal ATP concentration. Under physiological conditions, K (ATP) channels are predominantly in the closed state because of a strong inhibition of channel activity at an ATP i concentration in the millimolar range (Noma, 1983; Heidbu¨chel et al., 1990; Koumi et al., 1997) . These data are consistent with our observations in guinea-pig ventricular myocytes revealing no contribution of I K(ATP) to the basal electrical activity, since under physiological conditions the sulfonylurea glibenclamide (50 mM), a K (ATP) channel blocker, did not affect current -voltage relation elicited by a voltage ramp (data not shown).
In the present study, pinacidil, a K (ATP) channel opener (Smallwood & Steinberg, 1988; Arena & Kass, 1989) , which is known to increase the open probability of the K (ATP) channel (Isomoto & Kurachi, 1997) , activated I K(ATP) showing similar characteristics as described in other studies (Noma & Shibasaki, 1985; Arena & Kass, 1989; Koumi et al., 1997) .
Using a physiological (4.3 mM) and a low (1 mM) ATP i concentration, we could show that pinacidil causes a significantly more pronounced activation of I K(ATP) at a low ATP i concentration. These results are in line with previous observations reporting the pinacidil action to be dependent on ATP i with increasing sensitivity to openers at lower ATP i (Arena & Kass, 1989; Nakayama et al., 1990; Tseng & Hoffman, 1990; Pelzmann et al., 2001) . Thus, the pinacidil-primed I K(ATP) serves as an indicator of subsarcolemmal ATP concentration as demonstrated by Sasaki et al. (2001) .
The results of this study show that supplementation of guinea-pig ventricular myocytes with 300 mg ml À1 NADH (4 -6 h) causes a significantly reduced I K(ATP) activation by pinacidil compared to control cells, indicating an increased subsarcolemmal ATP concentration. These findings could be confirmed by measuring the intracellular adenine nucleotide content using HPLC, revealing a highly significant increase in ATP content in cardiomyocytes supplemented with NADH, whereas ADP and AMP did not significantly differ from control. Any direct effects of extracellular NADH on I K(ATP) could be excluded. Clinical studies have demonstrated a positive effect of NADH treatment on patients suffering from Morbus Parkinson, chronic fatigue syndrome and depression (Birkmayer & Birkmayer, 1991; Birkmayer et al., 1993; Kuhn et al., 1996; Forsyth et al., 1999) . Vrecko et al. (1997) showed that NADH supplementation of PC12 cells leads to increased dopamine production being of interest for the treatment of Morbus Parkinson which is characterized by a dopamine deficit. NADH-induced increase of dopamine release could also be shown in rat striatal slices (Pearl et al., 2000) . These data indicate that extracellular application of NADH results in cellular functional alterations, whereby the mechanisms are not completely understood. In nigrostriatal dopaminergic terminals release of dopamine is modulated by K (ATP) channels, whereby the extracellular concentration of dopamine is significantly decreased by the PCO cromakalim (Zhu et al., 1999) . Thus, modulation of K (ATP) channels obviously plays an important role in dopamine release, whereby a modulation of K (ATP) channel activity by NADH, as described in this work, could be of importance.
In summary, our data show that NADH supplementation, but not of the related compounds nicotinamide and NAD + , improves the metabolic state of isolated ventricular myocytes indicated by a decreased pinacidil-primed I K(ATP) . Measurement of adenine nucleotides confirmed a significant elevation of ATP levels in cardiomyocytes treated with NADH. The mechanism of this increase (elevated NADH/NAD + ratio, enhanced mitochondrial ATP production, enhanced intracellular reduction potential or NADH induced enzymatic alterations) is at present under investigation. NADH supplementation could be a useful pharmacological and therapeutical tool producing beneficial effects upon cell metabolism of cardiomyocytes and other high-energy-demanding cells in vivo. 
